Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Incannex Healthcare Q1 2026 Results: Net Loss of $1.94M, Loss Narrows

Incannex Healthcare Inc. reported a net loss from operations of $3.44 million for the quarter ended September 30, 2026, an improvement from a $6.79 million loss in the prior year period, primarily due to reduced general and administrative expenses. The company maintained a strong cash position of $68.27 million and continues to focus on its clinical development pipeline, including drug candidates IHL-42X and IHL-675A.

Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue0.00.0
Profit before tax-1.9-6.4
Net income-1.9-6.4
EPS (diluted, $ a share)$-0.15$-0.62

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: IXHL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Incannex Healthcare Inc.: key numbers

Share price
$1.74Close, Nov 17
Market cap
$21.8M
Shares outstanding
12.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.